• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2A 型血管性血友病患者伴重型颅脑创伤,采用凝血因子 VIII/von Willebrand 因子浓缩物治疗成功:病例报告。

Severe Traumatic Brain Injury in a Patient with von Willebrand Disease Type 2A Successfully Treated with Factor VIII/von Willebrand Factor Concentrates: A Case Report.

机构信息

Department of Emergency and Critical Care Medicine, University of Miyazaki Hospital, Miyazaki, Japan.

出版信息

Am J Case Rep. 2022 Aug 30;23:e936690. doi: 10.12659/AJCR.936690.

DOI:10.12659/AJCR.936690
PMID:36040865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9441215/
Abstract

BACKGROUND von Willebrand disease (VWD) is characterized by a bleeding tendency due to abnormalities in von Willebrand factor (VWF). Severe traumatic brain injury (TBI) can induce secondary coagulopathy and hemostatic disorders. We herein present a rare case of multiple trauma, including severe TBI, in a patient with VWD who was successfully treated with repeated factor VIII/VWF transfusion in addition to standard critical care. CASE REPORT A 22-year-old man with type 2A VWD sustained head and lower limb injuries in a traffic accident and was comatose. Computed tomography indicated multiple trauma, including severe TBI (left-sided traumatic epidural hematoma, left-sided traumatic subdural hematoma, traumatic subarachnoid hemorrhage, skull fracture, and skull base fracture). The patient underwent emergency craniotomy for hematoma removal, external decompression, and intracranial pressure monitoring along with massive transfusion and repeated perioperative transfusion of factor VIII/VWF concentrates according to the level of bleeding. He recovered consciousness and eventually survived without neurological deficits. CONCLUSIONS Multiple trauma including TBI in patients with VWD is a critical condition. The active transfusion of factor VIII/VWF is essential for controlling hemorrhage early and in the perioperative period.

摘要

背景

血管性血友病(VWD)的特征是由于血管性血友病因子(VWF)异常导致出血倾向。严重创伤性脑损伤(TBI)可引起继发性凝血功能障碍和止血紊乱。本文报告了一例罕见的 VWD 患者合并多处创伤,包括严重 TBI,除了标准重症监护外,还通过反复输注 VIII 因子/VWF 成功治疗。病例报告:一名 22 岁的 2A 型 VWD 患者在交通事故中头部和下肢受伤,处于昏迷状态。计算机断层扫描显示多处创伤,包括严重 TBI(左侧创伤性硬脑膜外血肿、左侧创伤性硬脑膜下血肿、创伤性蛛网膜下腔出血、颅骨骨折和颅底骨折)。患者接受紧急开颅血肿清除术、外减压术和颅内压监测,并根据出血程度进行大量输血和反复围手术期输注 VIII 因子/VWF 浓缩物。他恢复了意识,最终没有神经功能缺损而存活。结论:VWD 患者合并多处创伤,包括 TBI,是一种危急情况。积极输注 VIII 因子/VWF 对于控制早期和围手术期出血至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/9441215/6c2d5cf725b0/amjcaserep-23-e936690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/9441215/f1fe201c0bdb/amjcaserep-23-e936690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/9441215/1149a7772b85/amjcaserep-23-e936690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/9441215/6c2d5cf725b0/amjcaserep-23-e936690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/9441215/f1fe201c0bdb/amjcaserep-23-e936690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/9441215/1149a7772b85/amjcaserep-23-e936690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/9441215/6c2d5cf725b0/amjcaserep-23-e936690-g003.jpg

相似文献

1
Severe Traumatic Brain Injury in a Patient with von Willebrand Disease Type 2A Successfully Treated with Factor VIII/von Willebrand Factor Concentrates: A Case Report.2A 型血管性血友病患者伴重型颅脑创伤,采用凝血因子 VIII/von Willebrand 因子浓缩物治疗成功:病例报告。
Am J Case Rep. 2022 Aug 30;23:e936690. doi: 10.12659/AJCR.936690.
2
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
3
Von Willebrand's disease: case report and review of literature.血管性血友病:病例报告及文献综述
Pan Afr Med J. 2017 Jun 29;27:147. doi: 10.11604/pamj.2017.27.147.12248. eCollection 2017.
4
Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.应用重组血管性血友病因子成功治疗 1 例合并先天性血管性血友病和获得性血管性血友病综合征的小儿原位心脏移植患者的围术期管理
J Cardiothorac Vasc Anesth. 2022 Mar;36(3):724-727. doi: 10.1053/j.jvca.2021.01.038. Epub 2021 Jan 27.
5
Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.1型、2型和3型血管性血友病患者出血治疗和预防中静脉注射去氨加压素及血管性血友病因子/凝血因子VIII浓缩物的评估指南
Semin Thromb Hemost. 2006 Sep;32(6):636-45. doi: 10.1055/s-2006-949669.
6
Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.使用凝血因子VIII/血管性血友病因子浓缩物治疗血管性血友病:当前研究与调查结果
Blood Coagul Fibrinolysis. 2005 Apr;16 Suppl 1:S17-21. doi: 10.1097/01.mbc.0000167658.85143.49.
7
Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.血管性血友病——手术中的“注意事项”与“禁忌事项”
Eur J Haematol. 2017 Feb;98(2):121-127. doi: 10.1111/ejh.12809. Epub 2016 Oct 14.
8
Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.血管性血友病因子/凝血因子VIII浓缩物在血管性血友病治疗中的应用
Blood Coagul Fibrinolysis. 2009 Mar;20(2):89-100. doi: 10.1097/MBC.0b013e3283254570.
9
Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.在手术环境中使用去氨加压素和血管性血友病因子-凝血因子VIII浓缩物治疗1型、2型和3型血管性血友病患者。
Acta Haematol. 2009;121(2-3):167-76. doi: 10.1159/000214857. Epub 2009 Jun 8.
10
Treatment of von Willebrand disease.血管性血友病的治疗。
Semin Hematol. 2005 Jan;42(1):29-35. doi: 10.1053/j.seminhematol.2004.10.001.

引用本文的文献

1
Neurological Complications Associated with Hereditary Bleeding Disorders.遗传性出血性疾病相关的神经系统并发症。
Curr Neurol Neurosci Rep. 2023 Nov;23(11):751-767. doi: 10.1007/s11910-023-01313-y. Epub 2023 Oct 21.

本文引用的文献

1
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.美国血液学会(ASH)、国际血栓与止血学会(ISTH)、美国国家血友病基金会(NHF)、世界血友病联盟(WFH)2021年血管性血友病管理指南
Blood Adv. 2021 Jan 12;5(1):301-325. doi: 10.1182/bloodadvances.2020003264.
2
Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.血浆血管性血友病因子水平与静脉血栓栓塞症的未来风险。
Blood Adv. 2021 Jan 12;5(1):224-232. doi: 10.1182/bloodadvances.2020003135.
3
How I treat von Willebrand disease.我如何治疗血管性血友病。
Thromb Res. 2020 Dec;196:618-625. doi: 10.1016/j.thromres.2020.07.051. Epub 2020 Aug 3.
4
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.氨甲环酸对急性创伤性脑损伤患者死亡、残疾、血管阻塞事件和其他并发症的影响(CRASH-3):一项随机、安慰剂对照试验。
Lancet. 2019 Nov 9;394(10210):1713-1723. doi: 10.1016/S0140-6736(19)32233-0. Epub 2019 Oct 14.
5
Emergency management of patients with bleeding disorders: Practical points for the emergency physician.出血性疾病患者的急诊管理:急诊医生的实用要点
Transfus Apher Sci. 2019 Oct;58(5):553-562. doi: 10.1016/j.transci.2019.08.003. Epub 2019 Aug 6.
6
Utility of thromboelastography for the diagnosis of von Willebrand disease.血栓弹力描记术在血管性血友病诊断中的应用。
Pediatr Blood Cancer. 2019 Jul;66(7):e27714. doi: 10.1002/pbc.27714. Epub 2019 Apr 4.
7
Complications of Decompressive Craniectomy.减压性颅骨切除术的并发症
Front Neurol. 2018 Nov 20;9:977. doi: 10.3389/fneur.2018.00977. eCollection 2018.
8
Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience.血管性血友病因子/凝血因子VIII浓缩剂(Wilate®)的安全性和有效性:单中心经验
Haemophilia. 2014 Nov;20(6):846-53. doi: 10.1111/hae.12496. Epub 2014 Aug 7.
9
Early management of severe traumatic brain injury.严重创伤性脑损伤的早期处理。
Lancet. 2012 Sep 22;380(9847):1088-98. doi: 10.1016/S0140-6736(12)60864-2.
10
Elevated factor VIII levels and risk of venous thrombosis.VIII 因子水平升高与静脉血栓风险。
Br J Haematol. 2012 Jun;157(6):653-63. doi: 10.1111/j.1365-2141.2012.09134.x. Epub 2012 Apr 25.